Dr. Colm Henry:

We have actively included patient representation in the group looking at interval cancers which I have described. Those patients are contributing to that work and they understand, as do we and the Deputy, the importance of public confidence in the screening programmes. That involves public participation and quality assurance across the whole range of screening activity.